ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

circFOXM1 contributes to sorafenib resistance of hepatocellular carcinoma cells by regulating MECP2 via miR-1324

Weng, Hanqin; Zeng, Lexiang; Cao, Linhui; Chen, Tao; Li, Yanshan; Xu, Yunxiuxiu; Peng, Yaorong; Ye, Yibiao*南方医科大学; 中山大学; 东莞市人民医院
Molecular Therapy-Nucleic Acids2021-3-5DOI: 10.1016/j.omtn.2020.12.019
27被引13阅读
引用收藏
分享

摘要

As one of the most common malignant tumors, hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths around the world. Emerging studies have indicated that circular RNAs (circRNAs), which play a crucial role in HCC pathogenesis and metastasis, are differentially expressed in HCC. However, the regulatory mechanisms of circRNA on sorafenib resistance of HCC are still unknown. In our study, we identified a novel circRNA, circFOXM1, using RNA sequencing (RNA-seq) that was increased in sorafenib-resistant HCC tissues. Functionally, circFOXM1 significantly inhibited HCC growth and enhanced sorafenib toxicity in vitro. Mechanistically, circFOXM1 acted as a sponge of microRNA (miR)-1324, which is a negative regulator of MECP2, indicating that circFOXM1 downregulation would regulate sorafenib resistance of HCC via releasing more free miR-1324 and suppressing MECP2 expression. Furthermore, miR-1324 overexpression was capable of reversing the circFOXM1-induced malignant phenotypes and elevated expression of MECP2 in HCC cells. circFOXM1 partially contributed to sorafenib resistance of HCC cells through upregulating MECP2 expression by sponging miR-1324.

相关
加载中…
  • Circular RNA ITCH increases sorafenib-sensitivity in hepatocellular carcinoma via sequestering miR-20b-5p and modulating the downstream PTEN-PI3K/Akt pathway
    Li, Xiaodong; Yin, Xuedong; Bao, Heyi; Liu, Chang*Molecular and Cellular Probes, 2023, 67: 101877.被引 3
  • Circ_RBM23 knockdown suppresses chemoresistance, proliferation, migration and invasion of sorafenib-resistant HCC cells through miR-338-3p/RAB1B axis
    Xu, Chunlin; Sun, Weiwei; Liu, Jinglei; Pu, Haihong; Li, Yinghong*Pathology Research and Practice, 2023, 245: 154435.
  • Circular RNA CircITCH (has-circ-0001141) suppresses hepatocellular carcinoma (HCC) progression by sponging miR-184
    Guo, Xuan; Wang, Ziying; Deng, Xue; Lu, Yantong; Huang, Xuhui; Lin, Juze*; Lan, Xiaohe; Su, Qiao; Wang, Changjun*CELL CYCLE, 2022, 21(15): 1557-1577.被引 11
查看全部 →

发表信息

论文状态
公开发表
期刊
Molecular Therapy-Nucleic Acids
发表日期
2021-03-05
卷期
第 23 卷
页码
811-820
DOI
10.1016/j.omtn.2020.12.019
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Provincial Basic and Applied Basic Research Project (Provincial Natural Fund) Doctor startup project [2016A030310089]

作者

  • W

    Weng, Hanqin (第一作者)

    dongguan peoples hosp · southern med univ

  • Z

    Zeng, Lexiang

    sun yat sen univ

查看全部 8 位作者收起作者
  • C

    Cao, Linhui

    dongguan peoples hosp · southern med univ

  • C

    Chen, Tao

    dongguan peoples hosp · southern med univ

  • L

    Li, Yanshan

    dongguan peoples hosp · southern med univ

  • X

    Xu, Yunxiuxiu

    dongguan peoples hosp · southern med univ

  • P

    Peng, Yaorong

    sun yat sen univ

  • Y

    Ye, Yibiao (通讯)

    sun yat sen univ · dongguan peoples hosp · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417